Release of diclofenac sodium from polylactide-co-glycolide 80/20 rods

Due to inflammatory reactions complicating bioabsorbable devices, the aim of this study was to develop and characterize bioabsorbable implants with anti-inflammatory drug releasing properties. Polylactide-co- glycolide (PLGA) 80/20 was compounded with diclofenac sodium (DS) to produce rods. Thermal properties were analyzed using differential scanning calorimetry (DSC). Inherent viscosity (ηinh) was measured to evaluate the drug effect on the extrude polymer. Drug release measurements were performed using UV-spectrophotometer. Five parallel samples from each type of rods were examined, first at 6 hour intervals, then on daily basis, and later twice a week. DS was released in 110 days from thinner rods and in 150 days from thicker rods. Drug release comprised a starting peak, slow release phase, then a high release phase, and a burst release phase. DSC analysis showed that DS containing rods had crystallinity in their structure. In conclusions, it is feasible to combine PLGA 80/20 and DS by using melt extrusion. Released DS concentrations reached local therapeutic levels, but the release profile was complex and therapeutic levels were not reached all the time.

[1]  J. Heller,et al.  Biodegradable polymers in controlled drug delivery. , 1984, Critical reviews in therapeutic drug carrier systems.

[2]  O. Böstman,et al.  Adverse Tissue Reactions to Bioabsorbable Fixation Devices , 2000, Clinical orthopaedics and related research.

[3]  K. Ohya,et al.  The effect of sodium salicylate on the osteoclast-like cell formation and bone resorption in a mouse bone marrow culture , 1994, Calcified Tissue International.

[4]  P. Tarantili,et al.  Release of Propranolol and Diclofenac from Low Mw DL-Poly(Lactic Acid) , 2002, Journal of biomaterials applications.

[5]  A. Soekanto Inhibition of osteoclast-like cell formation by sodium salicylate and indomethacin in mouse bone marrow culture. , 1994, Japanese journal of pharmacology.

[6]  V. A. Skoutakis,et al.  Review of Diclofenac and Evaluation of its Place in Therapy as a Nonsteroidal Antiinflammatory Agent , 1988, Drug intelligence & clinical pharmacy.

[7]  K. Pavelka,et al.  Intraindividual Differences in Pain Relief and Functional Improvement in Osteoarthritis with Diclofenac or Tramadol , 1998, Clinical drug investigation.

[8]  A. Bernkop‐Schnürch,et al.  Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[9]  M. Ercan,et al.  Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. , 2000, International journal of pharmaceutics.

[10]  O. Böstman,et al.  Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. , 2000, Biomaterials.

[11]  M. Feldman,et al.  Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. , 1998, The American journal of medicine.

[12]  G. Im,et al.  The effect of COX-2 inhibitors on periprosthetic osteolysis. , 2004, Biomaterials.